Graves disease in a patient treated with dupilumab for severe asthma

Intern Med J. 2024 Apr;54(4):689-690. doi: 10.1111/imj.16375.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Asthmatic Agents* / adverse effects
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Asthma* / drug therapy
  • Double-Blind Method
  • Graves Disease* / complications
  • Graves Disease* / drug therapy
  • Humans

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized
  • Anti-Asthmatic Agents